Study of multiple, variable doses of GSK1521498

• Research type

  Research Study

• Full title

  A randomised, double-blind, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamic effects of 10 days of repeat dosing of GSK1521498 in overweight or obese but otherwise healthy subjects.

• IRAS ID

  29771

• Contact name

  Annelize Koch

• Contact email

  annelize.2.koch@gsk.com

• Sponsor organisation

  GlaxoSmithKline

• Eudract number

  2009-010552-97

• REC name

  East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

• REC reference

  WCPEC099

• Date of REC Opinion

  7 Nov 2012

• REC opinion

  Favourable Opinion